TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,020 | -75.8% | 450 | -80.0% | 0.01% | -78.3% |
| Q3 2022 | $29,000 | -9.4% | 2,250 | 0.0% | 0.02% | -4.2% |
| Q2 2022 | $32,000 | 0.0% | 2,250 | 0.0% | 0.02% | +20.0% |
| Q1 2022 | $32,000 | +3.2% | 2,250 | 0.0% | 0.02% | +5.3% |
| Q4 2021 | $31,000 | -16.2% | 2,250 | 0.0% | 0.02% | -20.8% |
| Q3 2021 | $37,000 | -17.8% | 2,250 | -15.1% | 0.02% | -17.2% |
| Q2 2021 | $45,000 | -6.2% | 2,650 | 0.0% | 0.03% | -14.7% |
| Q1 2021 | $48,000 | 0.0% | 2,650 | 0.0% | 0.03% | -2.9% |
| Q4 2020 | $48,000 | +2.1% | 2,650 | 0.0% | 0.04% | -5.4% |
| Q3 2020 | $47,000 | – | 2,650 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |